Clinical trial
Trial to Assess Chelation Therapy (TACT)
NCT00044213 · Mt. Sinai Medical Center, Miami, Other · Completed
Key facts
| NCT number | NCT00044213 |
|---|---|
| Title | Trial to Assess Chelation Therapy (TACT) |
| Official title | Trial to Assess Chelation Therapy (TACT) |
| Lead sponsor | Mt. Sinai Medical Center, Miami, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Center for Complementary and Integrative Health (NCCIH) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Dietary Supplement, Drug |
| Interventions | EDTA, EDTA Placebo, High Dose Vitamin, High Dose Vitamin Placebo |
| Enrollment | 1,708 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2011 |
| Completion | Aug 1, 2012 |
| First posted | Aug 23, 2002 |
| Last update posted | Nov 5, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: